Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024)
Creative Medical Technology Holdings (CELZ) posted quarterly Divestments of $6.5 million for Q1 2024, up 29.44% year-over-year from $5.0 million in Q2 2023, and down 62.42% quarter-over-quarter from $17.4 million in Q4 2023.
Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Divestments for 2 consecutive years, with $6.5 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Divestments rose 29.44% year-over-year to $6.5 million; the TTM figure through Dec 2024 stood at $6.5 million (down 75.3% YoY), while the FY2024 annual figure was $6.5 million, down 75.3% from the prior year.
- Divestments fell to $6.5 million in Q1 2024 per CELZ's latest filing, from $17.4 million in the prior quarter.
- Across five years, Divestments topped out at $17.4 million in Q4 2023 and bottomed at $11133.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -13.21 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 6.52 Mn |
| Dec 31, 2023 | 17.35 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 11,133.00 |
| Mar 31, 2023 | 5.04 Mn |